Genoray Co. Ltd
Genoray Co., Ltd. engages in the research, development, manufacture, and sale of medical and dental x-ray devices in South Korea. It offers C-ARM and mammography medical x-ray devices; and 2D, 3D, ENT, and IOS/IOX dental x-ray devices, as well as related maintenance and repair services. The company also exports its products to approximately 80 countries worldwide. Genoray Co., Ltd. was founded in… Read more
Genoray Co. Ltd (122310) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.008x
Based on the latest financial reports, Genoray Co. Ltd (122310) has a cash flow conversion efficiency ratio of 0.008x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩639.06 Million) by net assets (₩77.26 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Genoray Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Genoray Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Genoray Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Genoray Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
India Globalization Capital Inc
NYSE MKT:IGC
|
-0.258x |
|
Uniform Industrial Corp
TW:2482
|
0.009x |
|
Business Alignment Public Company Limited
BK:BIZ
|
-0.101x |
|
WooDeumGee Farm Co., Ltd
KQ:403490
|
0.033x |
|
Nanoveu Ltd
AU:NVU
|
-0.318x |
|
Avrupa Yatirim Holding AS
IS:AVHOL
|
0.093x |
|
Allmind Holdings Corporation
TWO:2718
|
0.093x |
|
Peña Verde S.A.B
MX:PV
|
0.009x |
Annual Cash Flow Conversion Efficiency for Genoray Co. Ltd (2015–2024)
The table below shows the annual cash flow conversion efficiency of Genoray Co. Ltd from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩85.89 Billion | ₩13.27 Billion | 0.155x | +315.37% |
| 2023-12-31 | ₩95.53 Billion | ₩3.55 Billion | 0.037x | -77.94% |
| 2022-12-31 | ₩87.96 Billion | ₩14.84 Billion | 0.169x | -13.58% |
| 2021-12-31 | ₩78.82 Billion | ₩15.38 Billion | 0.195x | +52.63% |
| 2020-12-31 | ₩66.53 Billion | ₩8.51 Billion | 0.128x | -28.49% |
| 2019-12-31 | ₩59.59 Billion | ₩10.65 Billion | 0.179x | +16.67% |
| 2018-12-31 | ₩44.97 Billion | ₩6.89 Billion | 0.153x | -16.72% |
| 2017-12-31 | ₩24.30 Billion | ₩4.47 Billion | 0.184x | -21.57% |
| 2016-12-31 | ₩14.80 Billion | ₩3.47 Billion | 0.235x | +26.88% |
| 2015-12-31 | ₩11.35 Billion | ₩2.10 Billion | 0.185x | -- |